While both medications showed a significant weight loss benefit, after 72 weeks on treatment, people treated with Zepbound lost 20% of their body weight, compared to people on Wegovy who lost just under 14%
Biggest exits drive ecosystem confidence Mega rounds + pharma acquisitions of biotech send the strongest external signal that obesity remains a top-priority therapeutic area
"Obesity is a chronic disease so we should treat it the same way as, say, high blood pressure, where you just take those drugs every single day for the rest of your life." Suzanne Rose, PhD, Executive Director of Research, Stamford Health If youre considering stopping the medication, its essential to work with your healthcare provider on a structured plan
Instead, it helps reduce appetite, improve fullness, and support a calorie deficit, which encourages the body to use stored fat for energy over time